Embla Medical hf.
OSSFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,702 | $1,673 | $1,772 | $1,676 |
| - Cash | $102 | $94 | $92 | $86 |
| + Debt | $562 | $565 | $529 | $500 |
| Enterprise Value | $2,162 | $2,144 | $2,209 | $2,089 |
| Revenue | $236 | $236 | $203 | $225 |
| % Growth | -0% | 16.4% | -9.8% | – |
| Gross Profit | $137 | $137 | $119 | $133 |
| % Margin | 58.2% | 58.1% | 58.7% | 59.2% |
| EBITDA | $55 | $45 | $35 | $44 |
| % Margin | 23.2% | 18.9% | 17% | 19.7% |
| Net Income | $26 | $21 | $12 | $18 |
| % Margin | 10.9% | 9% | 6% | 8.1% |
| EPS Diluted | 0.061 | 0.05 | 0.028 | 0.044 |
| % Growth | 21.2% | 78.6% | -36.4% | – |
| Operating Cash Flow | $46 | $22 | $14 | $42 |
| Capital Expenditures | -$5 | -$10 | -$6 | -$8 |
| Free Cash Flow | $41 | $12 | $8 | $34 |